KEGG   PATHWAY: oaa05330Help
Entry
oaa05330                    Pathway                                

Name
Allograft rejection - Ornithorhynchus anatinus (platypus)
Description
Allograft rejection is the consequence of the recipient's alloimmune response to nonself antigens expressed by donor tissues. After transplantation of organ allografts, there are two pathways of antigen presentation. In the direct pathway, recipient T cells react to intact allogeneic MHC molecules expressed on the surface of donor cells. This pathway would activate host CD4 or CD8 T cells. In contrast, donor MHC molecules (and all other proteins) shed from the graft can be taken up by host APCs and presented to recipient T cells in the context of self-MHC molecules - the indirect pathway. Such presentation activates predominantly CD4 T cells. A direct cytotoxic T-cell attack on graft cells can be made only by T cells that recognize the graft MHC molecules directly. Nontheless, T cells with indirect allospecificity can contribute to graft rejection by activating macrophages, which cause tissue injury and fibrosis, and are also likely to be important in the development of an alloantibody response to graft.
Class
Human Diseases; Immune diseases
BRITE hierarchy
Pathway map
Allograft rejection
oaa05330

All organismsOrtholog table
Organism
Ornithorhynchus anatinus (platypus) [GN:oaa]
Gene
MHC class I-2 antigen; K06751 major histocompatibility complex, class I [KO:K06751]
RLA class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
HLA class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
RLA class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
RT1 class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
zinc-alpha-2-glycoprotein-like; K06751 major histocompatibility complex, class I [KO:K06751]
RT1 class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
h-2 class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
RLA class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
DLA class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
T-lymphocyte activation antigen CD86-like; K05413 CD86 antigen [KO:K05413]
T-cell-specific surface glycoprotein CD28-like; K06470 CD28 antigen [KO:K06470]
uncharacterized LOC100086041; K05406 interleukin 12A [KO:K05406]
interleukin-12 subunit beta-like; K05425 interleukin 12B [KO:K05425]
tumor necrosis factor ligand superfamily member 6-like; K04389 tumor necrosis factor ligand superfamily member 6 [KO:K04389]
tumor necrosis factor receptor superfamily member 6-like; K04390 tumor necrosis factor receptor superfamily member 6 [KO:K04390]
perforin-1-like; K07818 perforin 1 [KO:K07818]
791103  
GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) [KO:K01353] [EC:3.4.21.79]
ORAN-DRA; MHC class II DR alpha [KO:K06752]
h-2 class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO:K06752]
CD40 ligand-like; K03161 tumor necrosis factor ligand superfamily member 5 [KO:K03161]
uncharacterized LOC100080275; K04687 interferon gamma [KO:K04687]
tumor necrosis factor-like; K03156 tumor necrosis factor superfamily, member 2 [KO:K03156]
uncharacterized LOC100077352; K05443 interleukin 10 [KO:K05443]
ig heavy chain V-III region VH26-like; K06856 immunoglobulin heavy chain [KO:K06856]
uncharacterized LOC100078549; K06856 immunoglobulin heavy chain [KO:K06856]
Compound
C00533  
Nitric oxide
Reference
  Authors
Arakelov A, Lakkis FG.
  Title
The alloimmune response and effector mechanisms of allograft rejection.
  Journal
Semin Nephrol 20:95-102 (2000)
Reference
  Authors
Le Moine A, Goldman M, Abramowicz D.
  Title
Multiple pathways to allograft rejection.
  Journal
Transplantation 73:1373-81 (2002)
Reference
  Authors
Trivedi HL.
  Title
Immunobiology of rejection and adaptation.
  Journal
Transplant Proc 39:647-52 (2007)
Reference
  Authors
Pietra BA.
  Title
Transplantation immunology 2003: simplified approach.
  Journal
Pediatr Clin North Am 50:1233-59 (2003)
Reference
PMID:8835634
  Authors
Oka T, Yoshimura N.
  Title
Immunosuppression in organ transplantation.
  Journal
Jpn J Pharmacol 71:89-100 (1996)
Reference
  Authors
Sayegh MH.
  Title
Why do we reject a graft? Role of indirect allorecognition in graft rejection.
  Journal
Kidney Int 56:1967-79 (1999)
Reference
  Authors
Benichou G.
  Title
Direct and indirect antigen recognition: the pathways to allograft immune rejection.
  Journal
Front Biosci 4:D476-80 (1999)
Reference
  Authors
Turvey SE, Wood KJ.
  Title
Immunobiology of solid organ transplantation.
  Journal
Int Surg 84:279-90 (1999)
Reference
  Authors
Janeway CA, Travers P, Walport M, Shlomchik MJ.
  Title
Immunobiology 6th edition
  Journal
Garland Science Publishing (2005)
Reference
  Authors
Game DS, Lechler RI.
  Title
Pathways of allorecognition: implications for transplantation tolerance.
  Journal
Transpl Immunol 10:101-8 (2002)
Reference
  Authors
Lechler RI, Garden OA, Turka LA.
  Title
The complementary roles of deletion and regulation in transplantation tolerance.
  Journal
Nat Rev Immunol 3:147-58 (2003)
KO pathway
 

DBGET integrated database retrieval system